Sonic is hurting in terms of competition as NZ contract demonstrates just how cutthroat and competitive pathology market is. This is also with Sonic facing competition from Healthscopes entrance into the Tasmanian market which Sonic previously had a monopoly over. The court cases against Healthscope (Symbion and one in Tassie where Sonic supposedly reported Healthscope) is more indicative of how aggressive competition is.
My advice is to get hell out of these stocks and wait for reporting that indicates they are back on even keel. I am beginning to think Healthscope might be showing signs of turning things around in a tightly contested market but no way I would invest my money in presently - but not to say after reporting in August and reassessing where it is at I might not then consider it as it has fallen far and does have quality assets.
But until then stay clear of health stocks such as Sonic, healthscope and Symbion.
- Forums
- ASX - By Stock
- what is the value now
Sonic is hurting in terms of competition as NZ contract...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$26.25 |
Change
-0.490(1.83%) |
Mkt cap ! $12.61B |
Open | High | Low | Value | Volume |
$26.12 | $26.98 | $25.84 | $49.14M | 1.879M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6466 | $26.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$26.26 | 3724 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6466 | 26.240 |
1 | 8313 | 26.190 |
1 | 38 | 26.150 |
2 | 860 | 26.110 |
1 | 25 | 26.100 |
Price($) | Vol. | No. |
---|---|---|
26.260 | 860 | 2 |
26.270 | 5012 | 1 |
26.300 | 5012 | 1 |
26.330 | 5012 | 1 |
26.350 | 5012 | 1 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
SHL (ASX) Chart |